Clonazepam 2 mg (Revotril)

Clonazepam 2 mg (REVOTRIL)

Widely known by the brand name Klonopin) is a long-acting prescription medication belonging to the benzodiazepine class of drugs. Chemically classified as a central nervous system (CNS) depressant, it is primarily prescribed to treat panic disorder and certain types of seizure disorders, including epilepsy, absence seizures, and Lennox - Gastaut syndrome. By altering specific chemical pathways in the brain, clonazepam produces pronounced anxiolytic (anti-anxiety), anticonvulsant, sedative, and muscle-relaxing effects.

When taken orally as a standard or disintegrating tablet, clonazepam is quickly and efficiently absorbed by the body, achieving a high bioavailability of roughly 90%. Peak concentrations in the bloodstream are typically reached within one to four hours after ingestion. Unlike fast-acting medications that leave the system quickly, clonazepam is characterised by an intermediate onset and an exceptionally long elimination half-life, which generally ranges from 30 to 40 hours.

This extended lifespan allows the drug to remain active in the body for 8 to 12 hours, providing stable, long-lasting relief but also increasing the potential for lingering next-day sedation. It is highly metabolized by the liver, meaning the organ breaks the chemical down before it is excreted.

The therapeutic action of clonazepam relies on its ability to enhance the function of gamma-aminobutyric acid (GABA), which is the primary inhibitory neurotransmitter in the central nervous system. Neurotransmitters serve as chemical messengers that allow brain nerves to communicate. When clonazepam binds to GABA-A receptors, it intensifies GABA's natural calming effect, effectively acting as a "brake pedal" to slow down hyperactive brain cells and abnormal electrical activity. 

This stabilisation prevents the sudden surge of electrical signals that trigger seizures and dampens the rapid, overwhelming nervous system response that fuels panic attacks.

Because of its strong impact on the central nervous system, clonazepam carries strict FDA Boxed Warnings regarding severe health risks. These warnings explicitly highlight the dangers of abuse, misuse, and addiction, as well as the risk of profound sedation, coma, or fatal respiratory depression if mixed with alcohol or opioid medications. Furthermore, because the brain rapidly adapts to the amplified GABA activity, long-term use frequently leads to physical dependence. 

If the medication is stopped abruptly rather than tapered down slowly under medical supervision, patients can suffer from life-threatening withdrawal symptoms, including severe tremors, hallucinations, or continuous, uncontrollable seizures. Common daily side effects include daytime drowsiness, memory problems, and ataxia (impaired walking and coordination).

SHOP